Regardless of market hypothesis of a significant discount in Nvidia Company’s NVDA 2025 Chip-On-Wafer-On-Substrate (CoWoS) wafer orders at Taiwan Semiconductor Manufacturing Co TSM, famend analyst Ming-Chi Kuo has debunked the rumors, confirming that TSMC’s enlargement plans stay on observe.
What Occurred: Market chatter prompt that Nvidia’s CoWoS wafer orders at TSMC had been minimize from over 400,000 wafers to 380,000 wafers, fueling considerations about AI demand fluctuations.
Nevertheless, on Monday, Kuo stated that these rumors have been probably primarily based on misinterpretations of Nvidia’s manufacturing technique and exaggerated expectations of TSMC’s capability.
“Nvidia’s CoWoS orders at TSMC for 2025 are roughly 370,000 wafers (variations inside low single digits are thought of regular vary),” he stated, including, “TSMC’s CoWoS enlargement plan stays unchanged … concentrating on roughly 70,000 wafers monthly by December 2025.”
Kuo additionally identified that some market members overestimated TSMC’s CoWoS capability and misinterpreted Nvidia’s faster-than-expected transition from B200 to B300 collection GPUs as an indication of order reductions.
Why It is Necessary: The CoWoS course of is crucial to Nvidia’s AI chip manufacturing, because it allows high-performance computing for GPUs utilized in information facilities and AI fashions.
Kuo’s report comes on the heels of Nvidia’s spectacular fourth-quarter earnings. The AI chip large reported fourth-quarter income of $39.3 billion, reflecting a 12% improve quarter-over-quarter and a 78% surge year-over-year.
The determine surpassed Wall Avenue’s consensus estimate of $38.05 billion.
In the meantime, TSMC reported fourth-quarter income of $26.88 billion (NT$868.46 billion), marking a 38.8% year-over-year improve and exceeding the analyst consensus estimate of $26.28 billion.
Value Motion: 12 months up to now, Nvidia inventory is down 9.68%, whereas TSMC inventory has declined 10.44%, based on Benzinga Professional information.
Learn Subsequent:
Disclaimer: This content material was partially produced with the assistance of Benzinga Neuro and was reviewed and printed by Benzinga editors.
Photograph courtesy: Shutterstock
Market Information and Information dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
